Overview

Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients

Status:
Withdrawn

Trial end date:
2008-01-01

Target enrollment:

Participant gender:

Summary

This is a randomized, double blind, placebo-controlled study, clinical trail designed to evaluate the efficacy safety and superiority of intravenous boluses of isosorbide dinitrate for the relief of acute anginal pain episodes in acute coronary syndrome patients in comparison with the usual manner of S/L isosorbide dinitrate .

Phase:

Phase 4

Details

Lead Sponsor:

Soroka University Medical Center

Treatments:

Isosorbide
Isosorbide Dinitrate
Isosorbide-5-mononitrate